Predicting macro- and microvascular complications in type 2 diabetes: The japan diabetes complications study/the japanese elderly diabetes intervention trial risk engine

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1193-1199

  Tanaka, Shiro ^a   Tanaka, Sachiko ^b   Iimuro, Satoshi ^c   Yamashita, Hidetoshi ^d   Katayama, Shigehiro ^e   Akanuma, Yasuo ^f   Yamada, Nobuhiro ^g   Araki, Atsushi ^h   Ito, Hideki ^h   Sone, Hirohito ^g   Ohashi, Yasuo ^c  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

^f INSTITUTE FOR ADULT DISEASES   (Japan)

^g UNIVERSITY OF TSUKUBA   (Japan)

^h Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C;

ACCURACY; AGE; ALBUMIN TO CREATININE RATIO; ALGORITHM; ARTICLE; BODY MASS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHEMICAL PARAMETERS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; GENDER; HEART ATRIUM FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNAL VALIDITY; ISCHEMIC HEART DISEASE; LEISURE; MACROVASCULAR DISEASE; MAJOR CLINICAL STUDY; MICROANGIOPATHY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; PHYSICAL ACTIVITY; PHYSICAL DISEASE BY ETIOLOGY AND PATHOGENESIS; PREDICTION; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SEARCH ENGINE; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE;

EID: 84876794062     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0958     Document Type: Article

References (37)

1. Coleman RL, Stevens RJ, Retnakaran R, Holman RR. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 2007;30: 1292-1293
2. Chamnan P, Simmons RK, Sharp SJ, Griffin SJ, Wareham NJP. Cardiovascular risk assessment scores for people with diabetes: A systematic review. Diabetologia 2009;52: 2001-2014
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053 (Pubitemid 38579764)
4. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140
5. Stevens RJ, Kothari V, Adler AI, Stratton IM; UnitedKingdomProspectiveDiabetes Study (UKPDS) Group. The UKPDS risk engine: A model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-679 (Pubitemid 33135349)
6. Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33:1776-1781 (Pubitemid 34761059)
7. Donnan PT, Donnelly L, New JP, Morris AD. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population. Diabetes Care 2006;29:1231-1236 (Pubitemid 44125915)
8. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K; DECODE Study Group; European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. Dia-betologia 2004;47:2118-2128 (Pubitemid 40174684)
9. Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjörnsdottir S; Swedish National Diabetes Register. Risk prediction of cardiovascular disease in type 2 diabetes: A risk equation from the Swedish National Diabetes Register. Diabetes Care 2008;31:2038-2043
10. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complication Study Group. Obesity and type 2 diabetes in Japanese patients. Lancet 2003; 361:85 (Pubitemid 36050984)
11. Sone H, Yoshimura Y, Ito H, Ohashi Y, Yamada N; Japan Diabetes Complications Study Group. Energy intake and obesity in Japanese patients with type 2 diabetes. Lancet 2004;363:248-249 (Pubitemid 38114733)
12. Katayama S, Moriya T, Tanaka S, et al.; Japan Diabetes Complications Study Group. Low transition rate from normo-and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS). Diabetologia 2011;54:1025-1031
13. Kawasaki R, Tanaka S, Tanaka S, et al.; Japan Diabetes Complications Study Group. Incidence and progression of diabetic ret-inopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 2011;54:2288-2294
14. Sone H, Mizuno S, Yamada N. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:1925-1927; author reply 1925-1927
15. Lee ET, Keen H, Bennett PH, Fuller JH, Lu M. Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Dia-betologia 2001;44(Suppl. 2):S3-S13 (Pubitemid 32844107)
16. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA 2002;287:2519-2527 (Pubitemid 34517197)
17. Yang X, So WY, Kong AP, et al. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care 2007;30: 65-70 (Pubitemid 46052501)
18. Yang X, So WY, Kong AP, et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Cardiol 2008;101: 596-601 (Pubitemid 351635559)
19. Yang X, So WY, Tong PC, et al.; Hong KongDiabetes Registry. Development and validation of an all-cause mortality risk score in type 2 diabetes. Arch Intern Med 2008;168:451-457 (Pubitemid 351547208)
20. Yang X, Ma RC, So WY, et al. Development and validation of a risk score for hospitalization for heart failure in patients with type 2 diabetes mellitus. Car-diovasc Diabetol 2008;7:9
21. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 2005;28:799-805 (Pubitemid 40434476)
22. Kokkinos P, Myers J, Nylen E, et al. Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes. Diabetes Care 2009; 32:623-628
23. Marwick TH, Hordern MD, Miller T, et al.; Council on Clinical Cardiology, American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Nutrition, Physical Activity, and Metabolism; Interdisciplinary Council on Quality of Care and Outcomes Research. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: A scientific statement from the American Heart Association. Circulation 2009;119:3244-3262
24. Colberg SR, Sigal RJ, Fernhall B, et al.; American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 2010;33:e147-e167
25. Muller-Riemenschneider F, Holmberg C, Rieckmann N, et al. Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study. Arch Intern Med 2010;170:719-724
26. Sone H, Tanaka S, Iimuro S, et al.; Japan Diabetes Complications Study Group. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: A nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 2010;53:419-428
27. Araki A, Iimuro S, Sakurai T, et al.; Japanese Elderly Diabetes Intervention Trial Study Group. Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trialdstudy design, baseline characteristics and effects of intervention. Geriatr Gerontol Int 2012; 12(Suppl. 1):7-17
28. Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res 2002;11:91-115 (Pubitemid 34516542)
29. The Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of hemoglobin A1c in Japan: from JDS to NGSP values [Internet]. Available from http://www.jds.or.jp/jds-or-jp0/uploads/photos/813.pdf. Accessed 31 January 2012
30. Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation 2003;107:2435-2439 (Pubitemid 36605225)
31. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: A second update of codes and MET values. Med Sci Sports Exerc 2011; 43:1575-1581
32. Sone H, Tanaka S, Tanaka S, et al.; Japan Diabetes Complications Study Group. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab 2011;96: 3448-3456
33. Wilkinson CP, Ferris FL 3rd, Klein RE, et al.; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682 (Pubitemid 37025422)
34. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27: 157-172; discussion 207-212 (Pubitemid 351193639)
35. National Institute for Clinical Excellence. Inherited Clinical Guideline H. Management of type 2 diabetes: management of blood pressure and blood lipids. London: National Institute for Clinical Excellence [article online], 2002. Available from http://www.nice.org.uk/nicemedia/pdf/NICE-INHERITEd-Hv8.pdf. Accessed at 25 April 2011
36. Wu AY, Kong NC, de Leon FA, et al. An alarmingly high prevalence of diabetic ne-phropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005;48:17-26 (Pubitemid 40174652)
37. Yokoyama H, Araki S, Haneda M, et al.; Japan Diabetes Clinical Data Management Study Group. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: A prospective cohort study (JDDM25). Diabetologia 2012;55: 1911-1918